| Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta … I Yunusa, A Alsumali, AE Garba, QR Regestein, T Eguale JAMA network open 2 (3), e190828-e190828, 2019 | 166 | 2019 |
| Cost-effectiveness analysis of bariatric surgery for morbid obesity A Alsumali, T Eguale, S Bairdain, M Samnaliev Obesity surgery 28, 2203-2214, 2018 | 86 | 2018 |
| The impact of bariatric surgery on pulmonary function: a meta-analysis A Alsumali, A Al-Hawag, S Bairdain, T Eguale Surgery for Obesity and Related Diseases 14 (2), 225-236, 2018 | 35 | 2018 |
| Cost effectiveness of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event from a US Medicare perspective A Alsumali, LM Djatche, A Briggs, R Liu, I Diakite, D Patel, Y Wang, ... Pharmacoeconomics 39, 1343-1354, 2021 | 25 | 2021 |
| Systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity A Alsumali, A Al-Hawag, M Samnaliev, T Eguale Surgery for Obesity and Related Diseases 14 (7), 1041-1059, 2018 | 25 | 2018 |
| Budget impact analysis of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening event A Alsumali, D Lautsch, R Liu, D Patel, S Nanji, LM Djatche Advances in Therapy 38, 2631-2643, 2021 | 22 | 2021 |
| Cost-effectiveness analysis of molnupiravir versus best supportive care for the treatment of outpatient COVID-19 in adults in the US H Goswami, A Alsumali, Y Jiang, M Schindler, ER Duke, J Cohen, ... PharmacoEconomics 40 (7), 699-714, 2022 | 18 | 2022 |
| Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective A Alsumali, RF Chemaly, J Graham, Y Jiang, S Merchant, LS Miles, ... Journal of medical virology 93 (6), 3786-3794, 2021 | 15 | 2021 |
| The impact of transsphenoidal surgery on neurocognitive function: a systematic review A Alsumali, DJ Cote, QR Regestein, E Crocker, A Alzarea, HA Zaidi, ... Journal of Clinical Neuroscience 42, 1-6, 2017 | 13 | 2017 |
| Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong TSY Chan, SSY Cheng, WT Chen, DC Hsu, RWY Chau, SH Kang, ... Journal of Medical Economics 23 (12), 1485-1492, 2020 | 11 | 2020 |
| Comparative efficacy of dual and single initiation of add-on oral antihyperglycemic agents in type 2 diabetes uncontrolled on metformin alone: a systematic literature review … D Lautsch, A Alsumali, E McLeod, Y Kuang, J He, R Singh, A Nevo, ... Diabetes Therapy 12, 389-418, 2021 | 9 | 2021 |
| Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes X Zhuo, CM Cohen, J Chen, G Chodick, A Alsumali, J Cook Journal of Diabetes and its Complications 36 (1), 108086, 2022 | 4 | 2022 |
| Budget impact of oral semaglutide intensification versus sitagliptin among US patients with type 2 diabetes mellitus uncontrolled with metformin E Wehler, D Lautsch, S Kowal, G Davies, A Briggs, Q Li, S Rajpathak, ... Pharmacoeconomics 39, 317-330, 2021 | 2 | 2021 |
| PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE A Alsumali, D Lautsch, S Kowal, Q Li, C Campbell, S Rajpathak, E Wehler Value in Health 23, S116, 2020 | 2 | 2020 |
| Prevalence, disease burden and unmet needs of patients with essential tremor: a systematic review and meta-analysis I Yunusa, P Abraham, A Alsumali, T Eguale Value in Health 21, S204-S205, 2018 | 2 | 2018 |
| Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH) V Mclaughlin, A Alsumali, R Liu, R Klok, EC Martinez, I Nourhussein, ... Advances in Therapy 41 (1), 130-151, 2024 | 1 | 2024 |
| PCV9 budget IMPACT analysis of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event in the United States A Alsumali, D Lautsch, R Liu, D Patel, S Nanji, L Djatche Value in Health 24, S68, 2021 | 1 | 2021 |
| Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States S Mahida, A Alsumali, AB Sawad Value in Health 21, S266, 2018 | 1 | 2018 |
| Blood pressure and neuropsychological test performance in healthy postmenopausal women A Alsumali, RA Mekary, J Seeger, Q Regestein Maturitas 88, 25-31, 2016 | 1 | 2016 |
| Real-World Medication Cost Burden Among Patients Treated for Pulmonary Arterial Hypertension A Watzker, C Ferro, G Dieguez, C Park, A Alsumali, D Lautsch, K El-Kersh C37. HEALTH SERVICES RESEARCH IN PULMONARY HYPERTENSION, A5427-A5427, 2024 | | 2024 |
